. Author manuscript; available in PMC: 2013 Aug 1.

Published in final edited form as: Biol Blood Marrow Transplant. 2012 Feb 10;18(8):1281–1286. doi: 10.1016/j.bbmt.2012.02.001

TABLE 2.

Multivariate analysis adjusting for the presence of busulfan in the conditioning regimen

	Adjusted^*
	OR (95% CI)	P
Diagnosis
AML	[1.0]	0.24
CML	0.49 (0.1–2.7)
MDS	2.00 (0.7–5.7)
Other	0.46 (0.1–2.7)
Conditioning
Cytoxan in conditioning regimen
No	[1.0]	0.63
Yes	1.44 (0.3–6.6)	0.63
Fludarabine in conditioning regimen
No	[1.0]	0.30
Yes	0.41 (0.1–2.4)	0.30
TBI in conditioning regimen
None	[1.0]	0.20
200 cGy	Undefined
>200 cGy	Undefined
Nonmyeloablative conditioning
No	[1.0]	0.49
Yes	0.51 (0.1–3.4)	0.49

Each factor adjusted for busulfan in conditioning regimen